Sponsor Pipeline

Mario Negri Institute for Pharmacological Research Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
46
Active Trials
23
Recruiting
2
Phase 3
6
Disease Areas
3
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-12 NCT05050214
Obinutuzumab in Primary MN
Trial completed
2026-08-12 NCT05050214
Obinutuzumab in Primary MN
date change Primary completion pushed: 2026-02 -> 2026-03-12
2026-08-12 NCT05050214
Obinutuzumab in Primary MN
date change Completion pushed: 2026-02 -> 2026-03-12
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-08-11 NCT07757711 Implementation of New Models of Ovarian Carcinoma Resistant to Therapy Not Yet Recruiting
Active Trials by Phase
Phase 4
1
Phase 3
1
Phase 2/3
1
Phase 2
4
Not specified
39
Active Trials — top 25 of 46
NCT IDTitleConditionStatus
Phase 4
NCT06121401 First Line Treatment With Olaparib in Combination With Bevacizumab in HRD Positive… Carcinoma, Ovarian Epithelial Active, Not Recruiting
Phase 3
NCT06858280 Patiromer and Diet/hrQoL in Chronic Dialysis Hyperkalaemia Recruiting
Phase 2/3
NCT06126315 Trial on the Biological and Clinical Effects of Acetyl-L-carnitine in ALS Amyotrophic Lateral Sclerosis Recruiting
Phase 2
NCT05482945 CardioPulmonary Resuscitation With Argon (CPAr) Trial Cardiac Arrest, Out-Of-Hospital Recruiting
NCT06680050 Phase II Study of Radiotherapy Followed by Durvalumab and Ceralasertib in Stage III NSCLC… Non Small Cell Lung Cancer NSCLC Recruiting
NCT07233330 Obinutuzumab in Adult Rituximab-Dependent Nephrotic Syndrome Nephrotic Syndrome,Idiopathic Not Yet Recruiting
NCT07428018 Pragmatic Study to Optimize Neoadjuvant Treatment and Surgical De-escalation in HR+/HER2… Breast Cancer Not Yet Recruiting
Not specified
NCT06374121 Kidney Perfusion With or Without Absorption Kidney Replacement Recruiting
NCT05612022 Acoustic Analysis of VA Sounds End Stage Renal Disease Recruiting
NCT04905264 Severe Acquired Brain Injuries: Prognostic Factors and Quality of Care Brain Injuries, Acute Recruiting
NCT06884410 Reproducibility of Multiparametric Renal Magnetic Resonance Imaging on 1.5T MRI Scanners Multiparametric MRI Recruiting
NCT06334692 Autoantibodies Against-nephrin in Idiopathic Nephrotic Syndrome Nephrotic Syndrome Recruiting
NCT06411353 Blood Flow Conditions and Sounds in AVFs End Stage Renal Disease Recruiting
NCT06841887 New Advanced Vascular Imaging Ultrasound Protocols Renal Diseases Recruiting
NCT05805202 Functional Implications of Rare Gene Mutations in aHUS Open the Door to Personalized… Atypical Hemolytic Uremic Syndrome Recruiting
NCT07331103 RESOLving INflammation Through Diet for Health (RESOLVIN) Cardiovascualr Disease Recruiting
NCT04095156 Autoreactive B Cells in Membranous Nephropathy Membranous Nephropathy Recruiting
NCT05996731 Developing a Pipeline to Employ RNA-Seq as a Complementary Diagnostic Tool in Rare… Atypical Hemolytic Uremic Syndrome Recruiting
NCT06242327 An Outcome Analysis of Primary Membranous Nephropathy Membranous Nephropathy Recruiting
NCT06846879 Evaluation of the Quality of Care in the Emergency Department by Studying the… Quality of Care Recruiting
NCT04676347 Health-care Quality in Semi-intensive Care Units Semi-intensive Care Unit Recruiting
NCT06354764 Propensity to Hospitalize Patients From the ED in European Centers. Emergency Medicine Recruiting
NCT06372379 Development of a Multipurpose Dashboard to Monitor the Situation of Emergency Departments Emergency Medicine Recruiting
NCT07021118 Mild TBI in the Emergency Department Emergency Departments Recruiting
NCT07683169 Trauma Molecular Processes Traumatic Brain Injury Recruiting
See all 46 active Mario Negri Institute for Pharmacological Research trials with filters →
Disease Areas
Get alerts when Mario Negri Institute for Pharmacological Research's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free